Disclaimer :
This Product Image is the Property of Arvantis Pharmaceuticals. Using this Product Image Without Prior Permission is Prohibited and Ignoring this Request May Lead to Legal Consequences.
Composition:-
Sitagliptin 50 mg, Metformin 500 mg
Description:-
Sitarv-M combines Sitagliptin 50 mg and Metformin 500 mg to help effectively manage Type 2 Diabetes Mellitus. It regulates blood sugar levels by improving insulin response and reducing glucose production. This dual-action tablet supports better glycemic control, making it a reliable choice for long-term diabetes management. Consult your healthcare professional before use for proper dosage and treatment guidance.
Enter your details to start WhatsApp chat
Tablets
Capsules
Softgels
Syrups & Susp.
Injectables
Drops
Cream-lotions
Dry Syrups
Others
